Cancer Pharmacy Workforce

Dear BOPA members 
 
Many of you may have noted the various workforce publications that have circulated recently.  As a committee we wanted to assure all members that BOPA has endeavoured to push for changes in any publications that we felt were not a true representation of the profession.   
 

  • The first publication was via Health Education England and was specific to Cancer (Dec17).  There was a rapid turnaround on responses for this and Geoff Saunders responded on behalf of BOPA – twe have circulated via email a copy of response Geoff submitted on behalf of BOPA response during the consultation period.   

 

  • A second HEE publication around workforce that detailed the full pharmacy workforce has been in consultation recently and as a committee we provided our views within the consultation period. 

 

 
We hope that you can use the attached and the CRUK document to drive change in workforce within your Trusts or Alliances.  
 
We now have a GAP  (Guidelines, Advocacy and Publications) committee that is dedicated to advocacy activities, this will ensure that wider consultation is achieved for any future publications.  
 
One final thing to note is that despite our best efforts in replying to consultation we have seen a trend for pharmacists to be not given enough priority in the final documents on cancer workforce, the focus is very much still on doctors and nurses. 
 
So our challenge for all our members is for you all to respond from your own organisation – the more pharmacy respondents there are in workforce consultations the better!!
 
Best Wishes
 
Steve Williamson on behalf of BOPA Exec Committee
 
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article